Prenatal alcohol exposure can result in fetal alcohol spectrum disorders (FASD), which can include physical and neurobehavioral disorders, including cognitive, social, language, and motor impairments that can persist throughout life. In order for children with FASD to receive the full benefit of services, recognition of their disability needs to be made earlier and more accurately than is common today. Early identification of an FASD helps to focus targeted treatments, reduce unnecessary medical steps and redundancy in medical care, and increase the likelihood of efficacious interventions. This article describes an innovative, brief screening tool designed to test the feasibility of screening for FASD risk in early intervention (EI) settings. Feasibility was demonstrated by a screening rate of 1161 (61%) of the 1896 available children. The primary resources needed for implementing FASD screening in EI programs are a brief FASD Screening Tool, an FASD trainer, and training time. Replication efforts would benefit from cost-free cross-training between EI sites and designated pediatricians/diagnosticians who are interested in improving their skills around FASD, and development of linkages with alcohol use disorder outpatient/assessment programs for possible referrals for birth mothers. The authors assert that it is practical and feasible to screen children for FASD in EI settings. Key words: alcohol-related neurodevelopmental disorder, alcohol-related birth defects, alcohol use disorders, developmental delays, developmental screening, early intervention, fetal alcohol syndrome, prenatal alcohol exposure, fetal alcohol spectrum disorders, maternal alcohol histories ''O F ALL substances of abuse (including cocaine, heroin, and marijuana),
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.